NIH Extends Agreement With BioFocus Until End 2012
BioFocus announced July 12 that the U.S. National Institutes of Health (NIH) have extended their agreement for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012. According to the terms of this agreement, BioFocus will be
BioFocus announced July 12 that the U.S. National Institutes of Health (NIH) have extended their agreement for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012. According to the terms of this agreement, BioFocus will be eligible to receive up to $8.6 million (€7.0 million) over the course of the two-year extension.
BioFocus runs a compound management facility for a number of industrial and U.S. government customers out of its Compound Focus, Inc. subsidiary in South San Francisco. Home to the MLSMR since 2004, this facility acquires and stores compounds under the NIH contract and distributes these compounds for high-throughput biological screening throughout the NIH’s academic network in the U.S.
“We are pleased that the NIH has exercised its option to extend its long-standing collaboration with BioFocus’ compound management facility for another two years. BioFocus has proven that it consistently delivers a high-quality service across the vast NIH screening center network,” said Onno van de Stolpe, CEO of Galapagos, BioFocus’ parent company.
Source: BioFocus